BMJ
March 2024
Objective: To compare the effectiveness of cervical pessary and vaginal progesterone in the prevention of adverse perinatal outcomes and preterm birth in pregnant women of singletons with no prior spontaneous preterm birth at less than 34 weeks' gestation and who have a short cervix of 35 mm or less.
Design: Open label, multicentre, randomised, controlled trial.
Setting: 20 hospitals and five obstetric ultrasound practices in the Netherlands.
Background: Preterm birth is in quantity and in severity the most important topic in obstetric care in the developed world. Progestogens and cervical pessaries have been studied as potential preventive treatments with conflicting results. So far, no study has compared both treatments.
View Article and Find Full Text PDFBMC Pregnancy Childbirth
July 2017